EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

The Protective Effects of N-Acetylserotonin Against Cisplatin-Induced Renal Injury: A Biochemical and Histopathological Study

Selçuk Yazıcı iD, Gülay Turan, Merve Akış Yılmaz iD, Büşra Aslan Akyol iD, Caner Yıldırım iD, Oğuzhan Korkut

International Journal of Molecular Sciences · 2026

DOI: 10.3390/ijms27093896 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2026. Verfasst von Selçuk Yazıcı und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pediatrics, Faculty of Medicine, Bezmialem University, 34093 Istanbul, Turkey. Hauptthemen laut MEDLINE: Cisplatin, Acute Kidney Injury, Serotonin, Protective Agents. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 45 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Cisplatin is a potent chemotherapeutic agent whose clinical application is frequently limited by severe nephrotoxicity. N-acetylserotonin (NAS), a precursor of melatonin and a selective agonist of the TrkB receptor, has demonstrated significant antioxidant and neuroprotective properties. This study aimed to evaluate the potential renoprotective effects of NAS against cisplatin-induced acute kidney injury (AKI) in a rat model. Thirty-five Wistar Albino rats were divided into five groups: Control, Sham, NAS (5 mg/kg), Cisplatin (CP; 7.5 mg/kg), and CP + NAS. NAS was administered daily for seven days, while cisplatin was given as a single dose on the fourth day. Renal function was assessed via serum urea and creatinine. Oxidative stress markers, including Malondialdehyde (MDA), Superoxide Dismutase (SOD), Total Antioxidant Status (TAS), and Total Oxidant Status (TOS), were measured in kidney tissue. Comprehensive histopathological evaluations were performed to assess tubular and glomerular damage. Cisplatin administration significantly increased serum creatinine levels and induced severe histopathological damage (p < 0.05). While cisplatin reduced SOD and TAS levels, NAS treatment showed a trend toward biochemical recovery without reaching statistical significance in oxidative markers. Notably, NAS administration significantly ameliorated cisplatin-induced histopathological lesions, specifically reducing tubular epithelial loss, glomerular degeneration, interstitial inflammation, and vacuolization (p < 0.05). Our findings indicate that NAS exerts a profound structural protective effect against cisplatin-induced renal injury. The preservation of renal parenchyma, despite modest systemic biochemical shifts, suggests that NAS-mediated protection may involve localized TrkB-dependent pro-survival signaling and stabilization of mitochondrial integrity. NAS represents a promising therapeutic candidate for mitigating chemotherapy-induced nephrotoxicity.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

CisplatinAcute Kidney InjurySerotoninProtective AgentsAnimalsRatsOxidative StressRats, WistarSuperoxide DismutaseAntioxidantsMaleKidneyAntineoplastic AgentsMalondialdehydeCreatinine

Stichwörter der Autor:innen

N-acetyl-5-hydroxytryptaminecisplatin-induced renal injurymalondialdehydesuperoxide dismutasetotal antioxidant statustotal oxidant status

Substanzen

CisplatinN-acetylserotoninSerotoninSuperoxide DismutaseAntioxidantsAntineoplastic AgentsMalondialdehydeCreatinineProtective Agents

Autor:innen und Institutionen

  • Department of Pediatrics, Faculty of Medicine, Bezmialem University, 34093 Istanbul, Turkey.
  • Department of Pathology, Faculty of Medicine, Balıkesir University, 10145 Balıkesir, Turkey.
  • Department of Biochemistry, Faculty of Medicine, Balıkesir University, 10145 Balıkesir, Turkey.
  • Department of Veterinary Pharmachology and Toxicology, Institute of Health Sciences, Balıkesir University, 10145 Balıkesir, Turkey.
  • Department of Biochemistry, Institute of Health Sciences, Balıkesir University, 10145 Balıkesir, Turkey.
  • Department of Clinical Pharmachology, Faculty of Medicine, Balıkesir University, 10145 Balıkesir, Turkey.

ORCID-Profile: Selçuk Yazıcı, Merve Akış Yılmaz, Büşra Aslan Akyol, Caner Yıldırım

Zitieren

APA

Yazıcı, S., Turan, G., Akış Yılmaz, M., Aslan Akyol, B., Yıldırım, C., & Korkut, O. (2026). The Protective Effects of N-Acetylserotonin Against Cisplatin-Induced Renal Injury: A Biochemical and Histopathological Study. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms27093896

Vancouver

Yazıcı S, Turan G, Akış Yılmaz M, Aslan Akyol B, Yıldırım C, Korkut O. The Protective Effects of N-Acetylserotonin Against Cisplatin-Induced Renal Injury: A Biochemical and Histopathological Study. International Journal of Molecular Sciences. 2026. doi:10.3390/ijms27093896

BibTeX
@article{Yazc2026,
  author = {Yazıcı, Selçuk and Turan, Gülay and Akış Yılmaz, Merve and Aslan Akyol, Büşra and Yıldırım, Caner and Korkut, Oğuzhan},
  title = {The Protective Effects of N-Acetylserotonin Against Cisplatin-Induced Renal Injury: A Biochemical and Histopathological Study},
  journal = {International Journal of Molecular Sciences},
  year = {2026},
  doi = {10.3390/ijms27093896}
}
Kostenlos starten →